Seven UK cases of Creutzfeldt-Jakob disease associated with transplanted human tissueApril 20, 2006Dura mater-associated Creutzfeldt-Jakob disease: Experience from surveillance in the UK Seven cases of Creutzfeldt-Jakob disease (CJD) associated with transplanted human tissue have occurred in the UK over a period of 33 years, reveals a study published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry. The seven cases of the fatal neurodegenerative disease were reported to the UK CJD surveillance system.
This monitors all cases of CJD arising sporadically, genetically, and as a result of infection from contaminated food products (variant form) or surgery (iatrogenic). The seven cases reported between 1970 and 2003 were the result of inadvertent transmission via transplanted human dura mater. Dura mater is the outermost, toughest, and most fibrous of the three membranes covering the brain and spinal cord. It is used in cranial and spinal surgical repair, and in various other procedures, such as the reinforcement of tendons and ligaments. CJD arose between four and 15 years after surgery, and was traced to one particular supplier in six of the seven cases. In the remaining case, the source was traced to pig tissue, and is believed to be the first such case in the world. The authors emphasise that transmission of CJD though the use of transplanted human dura mater is rare. Only 164 such cases have been identified around the globe, and most of these were treated with the product identified as the primary source in the UK cases. The risk to patients in the UK is unknown, say the authors, but research from Australia puts the risk as high as 1 in 500 for those treated between 1973 and 2003. In Japan, where some 20,000 human mater dura grafts are performed every year, the risk is put at between 1 in 1000 and 1 in 2000. More stringent selection criteria and better disinfection techniques introduced since 1987 may help to reduce the numbers of future cases arising from surgical transplants, suggest the authors. BMJ Specialty Journals | |||||||||||||||||||||
|
Related Creutzfeldt-Jakob Disease News Articles 'Intrabody' can mop up mutant protein in Huntington's disease model Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's. How small molecule can take apart Alzheimer's disease protein fibers Researchers from the University of Pennsylvania School of Medicine have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases. Seeing Alzheimer's amyloids In an important step toward demystifying the role protein clumps play in the development of neurodegenerative disease, researchers have created a stunning three-dimensional picture of an Alzheimer's peptide aggregate using electron microscopy. New insights into the diversity of Creutzfeldt-Jakob disease agents Researchers from the United Kingdom and France have identified four separate biochemical subgroups in a selection of cases of Creutzfeldt-Jakob disease. Blood transfusion-transmitted infections: A global perspective Thanks to the many blood-safety interventions introduced since 1984, the overall risk for most transfusion-transmitted infections has become exceedingly small. Call for data on reuse of surgical instruments to allay fears over vCJD transmission A study published today in the online edition of the Journal of the Royal Society Interface has been exploring the likelihood that vCJD might be spread via the reuse of surgical instruments, and calls for more data in order to allay fears over the possible transmission of vCJD. Prion disease agent causes heart damage in mouse study These findings raise the possibility that heart infection could be a new aspect of prion diseases, including those that affect humans and livestock, and that these diseases could travel through the blood. Prion find points way to test for human 'mad cow' disease In the July 7, 2006, issue of the journal Science, researchers at the University of Texas Medical Branch at Galveston (UTMB) describe experiments that may soon lead to a test that will enable medical science to estimate how many people are infected with the human form of mad cow disease, which can take as long as 40 years before manifesting itself. Brittle prions are more infectious Brittleness is often seen as a sign of fragility. But in the case of infectious proteins called prions, brittleness makes for a tougher, more menacing pathogen. Mad cow protein aids creation of brain cells Few conditions are more detrimental to human brains than the one popularly referred to as mad cow disease. More Creutzfeldt-Jakob Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||